Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan · Delayed Price · Currency is TWD 77.60
+1.60 (2.11%)
Feb 11, 2026, 2:00 PM CST
Steminent Biotherapeutics Market Cap
Steminent Biotherapeutics has a market cap or net worth of 5.06 billion as of February 10, 2026. Its market cap has increased by 347.33% in one year.
Market Cap
5.06B
Enterprise Value
4.98B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
77.60
Market Cap Chart
Since March 11, 2024, Steminent Biotherapeutics's market cap has increased from 2.24B to 5.06B, an increase of 126.06%. That is a compound annual growth rate of 53.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 5.19B | 29.62% |
| Dec 31, 2025 | 4.00B | 211.83% |
| Dec 31, 2024 | 1.28B | -42.67% |
| Mar 11, 2024 | 2.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Savior Lifetec | 6.19B |
| Sinphar Pharmaceutical | 5.82B |
| CHO Pharma | 5.76B |
| Locus Cell | 5.51B |
| Pharmosa Biopharm | 5.41B |
| Panion & Bf Biotech | 5.30B |
| UnicoCell Biomed | 5.26B |
| Senhwa Biosciences | 4.87B |